Hillhouse, CITIC PE Participate In $97M Round In BeiGene
May 14, 2015 — 16:04 CST
This Data Is Locked!
This area is available only to Subscribers.
Beijing-based Chinese oncology research and development firm BeiGene (Beijing), Co., Ltd. has completed a new round of financing worth RMB600 million (US$97 million) co-led by... [DATA LOCKED]
UNLOCK DATA
Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals
